Skip to main content
Premium Trial:

Request an Annual Quote

Thanks for the Golden Egg, Goose, But Don't Let the Door Hit You on Your Way Out

From the Wall Street Journal, here's a story that highlights the dramatic changes going on in the depths of big pharma. The feature article looks in particular at Pfizer and a round of layoffs it announced earlier this year -- among the 2,100 people cut was the inventor of Lipitor, "the bestselling pharmaceutical drug ever," according to the story.

If being responsible for some $80 billion in revenues doesn't bring job security, what does? According to the article, pharma is so mired in tough times, and new chemical compounds have proven so hard to come by, that chemists are being laid off with abandon. It's a good time to be thankful if you're one of the lucky pharma scientists working on biologics instead.


The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.